We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.73%
2 Healthcare 7.71%
3 Consumer Discretionary 6.84%
4 Financials 6.55%
5 Industrials 4.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KPRX icon
3426
Kiora Pharmaceuticals
KPRX
$11.3M
$15K ﹤0.01%
+475
New +$21.9K
KTOS icon
3427
Kratos Defense & Security Solutions
KTOS
$12.1B
$15K ﹤0.01%
1,493
-19,758
-93% -$196K
LCUT icon
3428
Lifetime Brands
LCUT
$226M
$15K ﹤0.01%
1,922
+402
+26% +$3.1K
LGIH icon
3429
LGI Homes
LGIH
$1.39B
$15K ﹤0.01%
165
-4,002
-96% -$366K
LVWR icon
3430
LiveWire
LVWR
$246M
$15K ﹤0.01%
2,914
+2,548
+696% +$17K
LYG icon
3431
Lloyds Banking Group
LYG
$90.1B
$15K ﹤0.01%
6,802
-32,999
-83% -$67.9K
LYRA
3432
DELISTED
LYRA THERAPEUTICS INC
LYRA
$15K ﹤0.01%
96
+26
+37% +$5.15K
MCB icon
3433
Metropolitan Bank Holding Corp
MCB
$1.17B
$15K ﹤0.01%
256
-3,419
-93% -$216K
MWA icon
3434
Mueller Water Products
MWA
$3.99B
$15K ﹤0.01%
1,418
-15,553
-92% -$174K
NEPH icon
3435
Nephros
NEPH
$50.3M
$15K ﹤0.01%
13,122
-1,114
-8% -$1.19K
NXDT
3436
NexPoint Diversified Real Estate Trust
NXDT
$264M
$15K ﹤0.01%
1,348
-628
-32% -$7.96K
OIS icon
3437
Oil States International
OIS
$539M
$15K ﹤0.01%
2,046
-8,224
-80% -$50.9K
OMF icon
3438
OneMain Financial
OMF
$7.56B
$15K ﹤0.01%
433
-557
-56% -$19.7K
ORC
3439
Orchid Island Capital
ORC
$1.33B
$15K ﹤0.01%
1,376
-17,238
-93% -$176K
OSW icon
3440
OneSpaWorld
OSW
$2.73B
$15K ﹤0.01%
1,645
-7,715
-82% -$73K
PAVS icon
3441
Paranovus Entertainment Technology
PAVS
$6.03M
0
PAYS icon
3442
Paysign
PAYS
$744M
$15K ﹤0.01%
6,031
-10,351
-63% -$25.9K
PHR icon
3443
Phreesia
PHR
$759M
$15K ﹤0.01%
470
-2,667
-85% -$72.4K
PROK icon
3444
ProKidney
PROK
$273M
$15K ﹤0.01%
2,245
+1,160
+107% +$11.1K
ALP
3445
Alpha Compute
ALP
$4.07M
$15K ﹤0.01%
142
+93
+190% +$11.4K
RANI icon
3446
Rani Therapeutics
RANI
$89.5M
$15K ﹤0.01%
2,507
+1,129
+82% +$8.23K
RSKD icon
3447
Riskified
RSKD
$875M
$15K ﹤0.01%
3,163
+338
+12% +$1.57K
SLDP icon
3448
Solid Power
SLDP
$552M
$15K ﹤0.01%
5,922
-31,562
-84% -$135K
SMHI icon
3449
SEACOR Marine Holdings
SMHI
$268M
$15K ﹤0.01%
1,633
-2,543
-61% -$19.7K
SNEX icon
3450
StoneX
SNEX
$8.09B
$15K ﹤0.01%
815
-16,241
-95% -$300K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.